Constituting a glutathione S-transferase-cocktail vaccine against tick infestation
Vaccine, ISSN: 0264-410X, Vol: 37, Issue: 14, Page: 1918-1927
2019
- 27Citations
- 36Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations27
- Citation Indexes27
- 27
- CrossRef8
- Captures36
- Readers36
- 36
- Mentions1
- News Mentions1
- 1
Most Recent News
Acaricidal and Repellent Efficacy of Cinnamomum verum Essential Oil Against Rhipicephalus microplus Ticks.
Byline: Muhammad Salman, Rao Zahid Abbas, Muhammad Kasib Khan and Muhammad Shahid Mahmood Key words Ticks, Rhipicephalus microplus, Essential oil, Cinnamomum verum, Acaricidal, Repellent Introduction
Article Description
Cocktail vaccines are proposed as an attractive way to increase protection efficacy against specific tick species. Furthermore, such vaccines made with different tick antigens have the potential of cross-protecting against a broad range of tick species. However, there are still limitations to the selection of immunogen candidates. Acknowledging that glutathione S-transferases (GSTs) have been exploited as vaccines against ticks and other parasites, this study aimed to analyze a GST-cocktail vaccine as a potential broad-spectrum tick vaccine. To constitute the GST-cocktail vaccine, five tick species of economic importance for livestock industry were studied ( Rhipicephalus appendiculatus, Rhipicephalus decoloratus, Rhipicephalus microplus, Amblyomma variegatum, and Haemaphysalis longicornis ). Tick GST ORF sequences were cloned, and the recombinant GSTs were produced in Escherichia coli. rGSTs were purified and inoculated into rabbits, and the immunological response was characterized. The humoral response against rGST-Rd and rGST-Av showed a stronger cross-reactivity against heterologous rGSTs compared to rGST-Hl, rGST-Ra, and rGST-Rm. Therefore, rGST-Rd and rGST-Av were selected for constituting an experimental rGST-cocktail vaccine. Vaccination experiment in rabbits showed that rGST-cocktail caused 35% reduction in female numbers in a Rhipicephalus sanguineus infestation. This study brings forward an approach to selecting immunogens for cocktail vaccines, and the results highlight rGST–Rd and rGST-Av as potentially useful tools for the development of a broad-spectrum tick vaccine.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0264410X19302464; http://dx.doi.org/10.1016/j.vaccine.2019.02.039; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85062007873&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/30824358; https://linkinghub.elsevier.com/retrieve/pii/S0264410X19302464; https://dx.doi.org/10.1016/j.vaccine.2019.02.039
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know